|
HS Code |
368347 |
| Chemical Name | Sulfamethoxypyridazine |
| Molecular Formula | C11H12N4O3S |
| Molecular Weight | 280.31 g/mol |
| Cas Number | 80-35-3 |
| Appearance | White to off-white crystalline powder |
| Melting Point | 214-216°C |
| Solubility In Water | Slightly soluble |
| Pharmacological Class | Sulfonamide antibacterial |
| Mechanism Of Action | Inhibits bacterial dihydropteroate synthase |
| Route Of Administration | Oral |
| Storage Conditions | Store at room temperature, away from light and moisture |
| Common Uses | Treatment of bacterial infections |
As an accredited Sulfamethoxypyridazine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 500g Sulfamethoxypyridazine supplied in a sealed, amber glass bottle with tamper-evident cap, labeled with product details and safety warnings. |
| Shipping | Sulfamethoxypyridazine is shipped in tightly sealed containers, protected from light, moisture, and incompatible substances. It should be handled according to safety regulations for chemicals, with clear labeling and documentation. Ground or air transport must comply with hazardous materials protocols, ensuring secure packaging to prevent leaks or contamination during transit. |
| Storage | Sulfamethoxypyridazine should be stored in a tightly closed container, protected from light and moisture. It should be kept at room temperature, ideally between 15°C and 30°C (59°F–86°F), in a dry, well-ventilated area away from incompatible substances. Avoid excessive heat and freezing temperatures. Ensure storage is secure and complies with local chemical safety regulations. |
Applications of Sulfamethoxypyridazine in Industrial ManufacturingSulfamethoxypyridazine, as manufactured by us under controlled synthesis and strict quality assurance, serves a critical role across specialist industrial and pharmaceutical sectors. Below, we present fully verified downstream applications, each highlighting distinct regulatory, formulation, process, and finished product considerations encountered by our global production partners. 1. Veterinary Pharmaceutical Formulations for LivestockThe veterinary pharmaceutical industry incorporates this active substance primarily in oral and injectable antibacterial formulations destined for large-scale livestock disease control. Manufacturers utilize it to address respiratory, gastrointestinal, and systemic infections in cattle, swine, and poultry. Formulation chemists pay careful attention to local residue and withdrawal regulations during product development. Quality controllers monitor batch consistency to comply with strict veterinary standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Aquaculture Disease Management ProductsThe aquaculture sector deploys this API in treatment protocols for bacterial infections in commercial fish and shrimp farming. Its spectrum addresses common pathogens affecting water livestock, under tightly regulated usage regimes to maintain aquatic safety and food chain integrity. Producers develop both feed medicaments and direct dosing agents tailored to intensive farm operations, always in line with strict environmental controls. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Companion Animal Therapeutic PreparationsPet pharmaceutical manufacturers formulate antibacterial oral tablets and suspensions for treating infections in dogs and cats. Quality assurance teams monitor precise dosing and safety profiles, mindful of regional medicine licensing. The finished drugs require careful packaging and extensive batch testing to ensure owner and animal safety before reaching the veterinary market. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Combined Sulfonamide and Trimethoprim Drug ManufacturingFinished drug plants, especially those producing combination therapies, use this sulfonamide as a principal partner with trimethoprim for treating bacterial infections resistant to single-agents. Strict impurity profiling and in-process blending ensure the product’s consistency and efficacy. Manufacturers integrate both actives at precise ratios, using validated process controls and continuous quality documentation per international pharmacopoeia monographs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Sulfamethoxypyridazine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Sulfamethoxypyridazine, known within production circles as a sulfonamide antibiotic, continues to meet the tough standards of animal health sectors worldwide. Through years of fine-tuning synthesis processes, our teams have found that the balance between purity and consistent particle size remains vital for any user aiming to achieve reliable outcomes in finished dosage forms. Looking back, the research and selection of model SMP95 for core veterinary applications wasn’t made on paper alone; hands-on challenges with solubility and cross-contamination risks in plant operation guided a shift toward this grade because it integrates cleanly—no stubborn residues, no unpredictable caking.
Our batches of SMP95 register consistently above 99% assay on dry basis, based on repeated HPLC analyses over hundreds of lots. Impurities stay well below the limits documented by most global pharmacopeias. Moisture content hovers between 0.2–0.5%, and particle size control, achieved using precision jet-milling, keeps average D50 values around 20–30 microns—figures reached only after eliminating standard hammer milling, which never quite addressed the dusting and loss problems. At these levels of process repeatability, chemical profile variations practically disappear across scale-ups or between year-to-year campaigns. We learned early on from feedback that anything less invited unnecessary batch failure or downtime for downstream mixers.
What makes sulfamethoxypyridazine stand apart from the more familiar sulfonamides? Experience in the pilot plant often brings out subtleties missed in literature reviews. Compared to sulfamethazine or sulfadimidine, sulfamethoxypyridazine holds a wider safety margin in poultry, swine, and bovine scenarios due to its lower tendency to precipitate in the urinary tract and an absorption curve that provides longer-lasting plasma levels. This means, for veterinary practitioners, fewer daily interventions and much lower risk of crystalluria, which matters to field operations chasing both efficacy and compliance. As manufacturers, we see this technical edge showing up in real-world purchasing decisions, guiding formulators who can’t risk last-minute recalls.
The highest demand for sulfamethoxypyridazine traces back to large-scale animal husbandry, where veterinarians and farm managers seek to manage outbreaks of respiratory and digestive tract infections. Our product gets deployed both as a single-ingredient powder and in combination with trimethoprim for synergistic effect. Through countless technical support visits, our staff see that farm hands value two qualities above all: a powder that disperses instantly and doesn’t leave stubborn clumps at the bottom of mixing tanks, and a product that holds up during long-term storage in humid conditions.
Shifting from warehouse feedback, it’s clear that earlier versions with wider particle size ranges caused lost doses on feed equipment, clogging on dosing lines, and visible sediment in final diluted stocks. A single percentage drop in fine control, confirmed by end-users and our in-house stability studies, made measurable difference at the distributor level. That feedback helped define the essential difference between us and traders packaging generic imports—direct control over synthesis and finished product ensures resistance to batch drift and meets veterinary expectations.
We chose to limit excipients in the production process, a decision shaped not from theory but after running stability trials with animal feeds under variable warehouse conditions. Results from pallets in unrefrigerated storage and exposed to seasonal moisture swings showed that excess bulking agents invite microbial risk and compromise shelf life, while leaner formulas kept assay levels steady for over two years. We continue to follow up with post-sale monitoring and field surveys of feed millers operating everywhere from dry climates to humid eastern provinces.
Building each batch of sulfamethoxypyridazine leaves little room for shortcuts; operating as the actual manufacturer goes beyond simple output targets. Our onsite lab handles constant method validation on each run, and the records tell a story of evolving detection techniques. In the past, reliance on crude titration or TLC couldn’t flag minor degradants, leaving downstream users open to compliance risk. Integrating automated HPLC and adopting real-time monitoring reduced out-of-spec incidents by over 40% within the first year, and that’s become a non-negotiable standard for our teams.
We notice that direct sales give us a detailed view of field-level feedback that distributors rarely forward. For example, switching to certified water supply for the last-stage crystallization step led to a measurable drop in lot-to-lot physical impurity complaints. A practical lesson: product quality hinges as much on upstream controls—reactor maintenance, filter integrity, and solvent quality—as on the final downstream packaging. Each seemingly minor adjustment addresses real-world needs.
Customers who blend products on global production lines share their own hurdles, often related to carrier media incompatibility or solubility drop-off in multi-component blends. By following up on onsite mixing observations, we’ve streamlined particle size dispersal and avoided common pitfalls like agglomeration, which can otherwise cause bridging inside feed blenders and dosage inconsistencies across entire shipments. These are solutions guided by on-the-ground manufacturing insight, rather than rigid catalog standards.
The industry faces steady regulatory tightening on residual antibiotics in food and the growing pressure to use actives with clearer withdrawal periods and lower resistance triggers. Our formulation of sulfamethoxypyridazine meets these needs far better than legacy sulfonamides; we see much fewer cases where residue testing fails at slaughterhouses, saving producers significant loss and administrative back-and-forth. Longer half-life reduces peak-trough fluctuations, so field staff dose less frequently and achieve higher compliance. For both large integrators and smaller family farms, operational efficiency supports bottom-line profit.
Cost control also plays a defining role. As the manufacturer, we know firsthand that bulk pricing isn’t the only calculation driving repeat orders. The hidden costs—like time lost to poorly flowing powders, shipment rejections due to clumping, or unexpected regulatory audits—mount quickly if the raw material doesn’t start with a tight specification. By maintaining in-house quality control and direct accountability, we shield our buyers from these risks, responding rapidly to shift in market demand or new national standards for drug residues.
Many alternatives exist—sulfadiazine, sulfadimidine, and modern broad-spectrum agents—but users repeatedly return to sulfamethoxypyridazine for its combination of dependable activity and margin of safety. Direct supply relationships with veterinary pharma companies strengthen our ability to adapt process tweaks to regional requirements, confirming in practice what academic literature sometimes only speculates about cross-tolerances or metabolic profiles in different animal species.
It’s tempting to view all antibiotic actives as interchangeable when comparing from a desktop. Walking the plant floor, patterns emerge that don’t show up in generic COA tables. True, every buyer checks paperwork—assay, moisture, heavy metals, microbial limits—but most errors that cause a shipment to fail in transit or at customs trace back to overlooked production practices: cleaning validation, raw material sourcing, even operator training.
Continuous product review sessions and investment in analytical upgrades form the backbone of repeatable output. Our line staff have completed thousands of hours in GMP and safety training, raising red flags during routine monitoring. Real mistakes—contaminated water, filter fibers, accidental cross-charging—shape procedures more than any outside audit. As one concrete example, after a single incident of visible particulate matter in a bulk drum, we instigated a root-cause analysis, retrained four shifts, and implemented inline controls that catch contaminants before they reach the blending room.
Quality assurance builds trust with each shipment. Every box stamped with our lot code is traceable from reactor charge to warehouse outgate. Customers don’t settle for average; they look for suppliers who can deliver the same parameters six shipments in a row or switch grades at short notice without changes in performance. Over years of partnership, we’ve seen that these relationships are built on transparency about deviations and willingness to correct near-misses before the problems turn into regulatory violations.
Staying current means more than updating certificates. Recent regulatory changes in key markets, plus rising consumer awareness about antibiotic residues, shape not only our production targets but the frequency and type of safety checks we run. Market leaders in food production set new targets for lower daily antibiotic use and push for shorter withdrawal periods. Sulfamethoxypyridazine’s pharmacokinetic profile aligns with these trends, offering reliable coverage with reduced risk of residue holdover in edible tissues.
As a manufacturer, we see the push toward “greener,” more process-efficient chemistry not as a passing trend but as a way to secure market share in a climate-conscious world. Process optimization reduces waste streams; solvent recycling cuts down environmental load; and integrated emissions controls address upstream and downstream compliance. These aren’t responses to marketing slogans but hard-learned strategies to protect both local ecosystems and long-term access to overseas buyers. Clean chemistry doesn’t just win awards, it ensures continued licensing and fewer disruptions from inspections.
Field audits by major integrators and government inspectors have grown more unpredictable. Tracing raw materials back to their origin, verifying cleaning schedules, and running random stability tests on shelved stock all come with their challenges. We’ve built robust response mechanisms for audits—dedicated staff, real-time documentation access, and scheduled “shutdown-and-review” days where production stops for thorough troubleshooting and preventive maintenance.
True customer service doesn’t end at delivery. Our technical teams regularly visit client mixing plants to observe blending, answer field questions, and assist with troubleshooting unusual solubility or flow challenges. On occasion, we catch issues arising from changes in water hardness or unexpected humidity spikes during rainy seasons. Adjusting the blend or offering onsite modifications to mixing protocols has kept shipment claims to a minimum.
Long-term buyers often share that consistency in performance ranks higher than a marginally lower invoice price. We’ve learned to take complaints seriously, even those that seem trivial or rare. Early signals—like delayed mixing times during hot spells or slightly hazy solutions in cold weather—become opportunities to revisit batching parameters, improve drying steps, or shorten packaging times to lock in freshness.
Extending service beyond sales, we’ve developed field guides and hosted seminars for large animal producers on topics ranging from preventing cross-contamination during bulk storage to managing medicine withdrawals efficiently. These efforts aren’t about selling more but seeing clients get the most value with minimum waste, building loyalty through practical, evidence-backed support. Hands-on advice and access to real people, not just an email portal, make a difference in annual contract renewals.
On the production side, people sometimes overlook the details that set one supplier apart from another. For example, some factories still run legacy batch reactors with loose process controls, leading to spotty performance and off-color material. By investing in batch-to-batch analytics and final sieve checks, we catch rogue lots before they cause downstream patchwork correction. Our standard format, SMP95, consistently wins feedback for its off-white powder profile, easy dissolve rate, and freedom from grit or foreign odor—characteristics reflect direct control over every input, not just lab paperwork.
Being both bulk manufacturer and final product blender, we bring rare synergy to the market. Immediate access to upstream process parameters helps us answer distributor and client questions in real time—no guesswork, no delayed approvals. Having weathered raw material price hikes, new EU and FDA rules, and the occasional container backlog, we know that building slack into the system—buffer stock, in-house testing, documented supplier audits—keeps the product on the shelf and raw material risk at bay.
Looking critically at claims made by alternative sulfonamides, many fail to provide the shelf stability or granular precision required by today’s automated dosing lines. Our experience running side-by-side trials in commercial feed production environments revealed that product format affects not only technical output but also business outcomes—less wastage during transfer, sharper dose control, and a lower chance of end-user mishaps. These operational gains don’t appear in basic specification sheets, but year-over-year, they keep buyers from switching to generic vendors.
Responsibility means more than what happens inside the facility gates. As stewards of the chemical supply chain, we work with global partners to make traceability and product stewardship central. Real-world challenges—global pandemics, shipping faults, and unexpected changes in livestock disease trends—place new demands on timing and delivery. Because we hold final manufacturing, shipping, and quality release authority, we’re able to respond to changes without passing delays or uncertainties down the line.
Philosophy matters as well. We choose transparency over hard-sell tactics. Problems arise in every long-term supply relationship, from weather-damaged raw materials to shifting customs interpretations. An open book approach—flagging possible supply chain issues, updating clients directly on observed anomalies, and encouraging feedback loops—protects everyone from last-minute surprises. We view every order, and every feedback call, as a chance to refine both product and service.
A chemical manufacturer’s perspective brings unique accountability. We see each batch of sulfamethoxypyridazine through a different lens than traders or third-parties. Every step, from sourcing raw input to confirming post-shipment feedback, helps us shape products that do more than tick boxes on regulatory lists. They perform predictably in diverse real-world environments, save producers from downtime, and strengthen confidence in the entire supply chain.
Manufacturing isn’t theory—it’s daily reality in raw materials, process control, and customer experience. For us, sulfamethoxypyridazine stands as more than another product code. It’s the living result of hands-on engineering, unfiltered feedback from the field, and a drive to do right by partners whose livelihoods ride on every delivery. Consistency, openness, and willingness to improve aren’t optional; they’re what keep the product—and the industry—relevant for years to come.